1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Puerto Rico Pharmaceuticals and Healthcare Report Q1 2016

Puerto Rico Pharmaceuticals and Healthcare Report Q1 2016

  • November 2015
  • -
  • Business Monitor International
  • -
  • 91 pages

Includes 3 FREE quarterly updates

BMI View: While the forecast for Puerto Rico has remained at a stable trajectory, the US territory is facingan uncertain future, caused by US congressional healthcare decisions that much of the island's populationfeel will lead to widespread economic harm. In addition to this, Puerto Rico's reputation as being a hub ofpharmaceutical and biotech manufacturing is in jeopardy due to changes to US laws that protectedmultinational manufacturing companies based there from US taxes.

Headline Expenditure Projections

? Pharmaceuticals: USD3.02bn in 2014 to USD3.03bn in 2015; 0.28%. Forecast on par with Q415.

? Healthcare: USD7.79bn in 2014 to USD8.07bn in 2015; +3.7%. Forecast unchanged since Q315.

Table Of Contents

Puerto Rico Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Puerto Rico 2013-2019) 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Puerto Rico 2013-2019) 9
SWOT 10
Industry Forecast 13
Pharmaceutical Market Forecast 13
Table: Pharmaceutical Sales, Historical Data And Forecasts (Puerto Rico 2011-2019) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Puerto Rico 2011-2019) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Puerto Rico 2011-2019) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Puerto Rico 2011-2019) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Puerto Rico 2011-2019) 23
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Puerto Rico 2011-2019) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Puerto Rico 2013-2019) 29
Pharmaceuticals and Healthcare Risk/Reward Index 30
Americas Risk/Reward Index 30
Puerto Rico Risk/Reward Index 37
Rewards 37
Risks 38
Regulatory Review 39
Pricing And Reimbursement 39
Tax Incentives 40
Table: Incentives, Benefits And Discounts For Pharmaceutical Manufacturers 42
Trade Accords 43
Market Overview 44
Epidemiology 44
Healthcare Sector 46
Effects Of US Healthcare Reform 47
Healthcare Financing 49
Healthcare Provision 49
Medical Tourism 50
Research and Development 51
Biotechnology 52
Clinical Trials 52
Competitive Landscape 54
Pharmaceutical Industry 55
Table: Major International Drugmakers In Puerto Rico 55
Pharmaceutical Production 57
Plant Expansions 57
Table: Puerto Rico - Multinationals' Operations 59
Plant Closures 60
Company Developments 60
Table: Multinational Company Activity 61
Pharmaceutical Distribution 61
Pharmaceutical Retail 62
Company Profile 64
Abbott Laboratories 64
Eli Lilly 67
GlaxoSmithKline 70
Merck 73
Novartis 76
Sanofi 78
Demographic Forecast 80
Table: Population Headline Indicators (Puerto Rico 1990-2025) 81
Table: Key Population Ratios (Puerto Rico 1990-2025) 81
Table: Urban/Rural Population and Life Expectancy (Puerto Rico 1990-2025) 82
Table: Population By Age Group (Puerto Rico 1990-2025) 82
Table: Population By Age Group % (Puerto Rico 1990-2025) 83
Glossary 85
Methodology 87
Pharmaceutical Expenditure Forecast Model 87
Healthcare Expenditure Forecast Model 87
Notes On Methodology 88
Risk/Reward Index Methodology 89
Index Overview 90
Table: Pharmaceutical Risk/Reward Index Indicators 90
Indicator Weightings 91

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.